LOW EXPRESSION OF NIBRIN PREDICTS BETTER PROGNOSIS IN PATIENTS WITH OVARIAN CANCER TREATED WITH TRABECTEDIN PLUS PEGYLATED LIPOSOMAL DOXORUBICIN (PLD)

被引：0
|
作者：
Aracil, M. [1 ]
Nieto, A. [1 ]
Tanovic, A. [2 ]
Monk, B. J. [3 ]
Kaye, S. B. [4 ]
Poveda, A. [5 ]
Herzog, T. J. [6 ]
Parekh, T. [7 ]
Badri, N. [2 ]
Galmarini, C. M. [1 ]
机构：
[1] PharmaMar, Dept Res & Dev, Madrid, Spain
[2] PharmaMar, Med Affairs, Madrid, Spain
[3] St Josephs Hosp, Creighton Univ Sch Med, Div Gynecol Oncol, Phoenix, AZ USA
[4] Royal Marsden Hosp, Dept Canc Med, Sutton, Surrey, England
[5] Valencian Inst Oncol, Dept Gynecol Oncol, Valencia, Spain
[6] Columbia Univ Coll Phys & Surg, Div Gynecol Oncol, New York, NY 10032 USA
[7] Janssen LLC, Dept Res & Dev, Raritan, NJ USA
来源：
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER | 2013年 / 23卷 / 08期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Trabectedin plus pegylated liposomal doxorubicin (PLD) versus PLD in recurrent ovarian cancer: Overall survival analysis
    Monk, Bradley J.
    Herzog, Thomas J.
    Kaye, Stanley B.
    Krasner, Carolyn N.
    Vermorken, Jan B.
    Muggia, Franco M.
    Pujade-Lauraine, Eric
    Park, Youn C.
    Parekh, Trilok V.
    Poveda, Andres M.
    EUROPEAN JOURNAL OF CANCER, 2012, 48 (15) : 2361 - 2368
  • [2] Trabectedin Plus Pegylated Liposomal Doxorubicin in Recurrent Ovarian Cancer
    Monk, Bradley J.
    Herzog, Thomas J.
    Kaye, Stanley B.
    Krasner, Carolyn N.
    Vermorken, Jan B.
    Muggia, Franco M.
    Pujade-Lauraine, Eric
    Lisyanskaya, Alla S.
    Makhson, Anatoly N.
    Rolski, Janusz
    Gorbounova, Vera A.
    Ghatage, Prafull
    Bidzinski, Mariusz
    Shen, Keng
    Ngan, Hextan Yuen-Sheung
    Vergote, Ignace B.
    Nam, Joo-Hyun
    Park, Youn Choi
    Lebedinsky, Claudia A.
    Poveda, Andres M.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (19) : 3107 - 3114
  • [3] Trabectedin in combination with pegylated liposomal doxorubicin for patients with ovarian cancer
    Tavella, K.
    Villanucci, A.
    Vannini, L.
    Montelatici, S.
    Lavacchi, D.
    Boni, L.
    Tomcikova, D.
    Amunni, G.
    Mazzei, T.
    ANNALS OF ONCOLOGY, 2016, 27
  • [4] Trabectedin plus pegylated liposomal doxorubicin (PLD) for patients with platinum-sensitive recurrent ovarian cancer: a prospective, observational, multicenter study
    Ingo B. Runnebaum
    Dietmar Reichert
    Uta Ringsdorf
    Markus Kuther
    Tobias Hesse
    Jalid Sehouli
    Pauline Wimberger
    Journal of Cancer Research and Clinical Oncology, 2018, 144 : 1185 - 1195
  • [5] Trabectedin plus pegylated liposomal doxorubicin (PLD) for patients with platinum-sensitive recurrent ovarian cancer: a prospective, observational, multicenter study
    Runnebaum, Ingo B.
    Reichert, Dietmar
    Ringsdorf, Uta
    Kuther, Markus
    Hesse, Tobias
    Sehouli, Jalid
    Wimberger, Pauline
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2018, 144 (06) : 1185 - 1195
  • [6] Trabectedin plus pegylated liposomal doxorubicin: the return of a treatment option for ovarian cancer Foreword
    Clare, John
    FUTURE ONCOLOGY, 2013, 9 (12) : 1 - 1
  • [7] AN OBSERVATIONAL, MULTICENTER, PROSPECTIVE STUDY OF TRABECTEDIN PLUS PEGYLATED LIPOSOMAL DOXORUBICIN (PLD) IN PATIENTS WITH PLATINUM-SENSITIVE RECURRENT OVARIAN CANCER (PSROC)
    Reichert, D.
    Wimberger, P.
    Ringsdorf, U.
    Krohn, M.
    Kuther, M.
    Runnebaum, I.
    Sehouli, J.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2017, 27 : 1717 - 1717
  • [8] TRABECTEDIN AND PEGYLATED LIPOSOMAL DOXORUBICIN (PLD) VERSUS CARBOPLATIN AND PLD IN PARTIALLY PLATINUM-SENSITIVE OVARIAN CANCER PATIENTS: INOVATYON STUDY
    Colombo, N.
    Biagioli, E.
    Copreni, E.
    Floriani, I.
    Fossati, R.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2014, 24 (09) : 457 - 457
  • [9] AN OBSERVATIONAL, MULTICENTER, PROSPECTIVE STUDY OF TRABECTEDIN PLUS PEGYLATED LIPOSOMAL DOXORUBICIN (PLD) IN PATIENTS WITH PLATINUM-SENSITIVE RECURRENT OVARIAN CANCER (PSROC)
    Reichert, D.
    Wimberger, P.
    Ringsdorf, U.
    Krohn, M.
    Kuther, M.
    Runnebaum, I.
    Sehouli, J.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2017, 27 : 558 - 558
  • [10] Tolerability and efficacy of trabectedin plus pegylated liposomal doxorubicin (PLD) in elderly patients with ovarian cancer (OC): GEICO 105-O study
    Rubio Perez, M. J.
    Manzano Fernandez, A.
    De Sande Gonzalez, L. M.
    Estevez Garcia, P.
    Gordon Santiago, M. D. M.
    Soto De Prado, D.
    Hernando Fernandez, B. A.
    Guerra Alia, E. M.
    Carbo Bague, A.
    Romero, I.
    Corbellas Aparicio, M.
    Gonzalez-Haba Martinez, A.
    Robles Barraza, C. E.
    Martinez-Garcia, J.
    Gonzalez Martin, A.
    ANNALS OF ONCOLOGY, 2023, 34 : S523 - S523
12345